RASI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.209
EU - Europa 1.159
AS - Asia 618
SA - Sud America 55
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 11
Totale 3.066
Nazione #
US - Stati Uniti d'America 1.159
IE - Irlanda 247
SG - Singapore 227
IT - Italia 210
DE - Germania 199
SE - Svezia 160
CN - Cina 131
HK - Hong Kong 112
UA - Ucraina 85
RU - Federazione Russa 65
FI - Finlandia 61
IN - India 60
GB - Regno Unito 52
BR - Brasile 41
CA - Canada 32
FR - Francia 29
VN - Vietnam 28
KR - Corea 17
MX - Messico 15
ES - Italia 12
EU - Europa 11
PL - Polonia 9
BD - Bangladesh 8
BJ - Benin 8
IR - Iran 8
JP - Giappone 8
NL - Olanda 8
TR - Turchia 8
AR - Argentina 5
BE - Belgio 5
ZA - Sudafrica 4
AT - Austria 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CL - Cile 2
ID - Indonesia 2
IQ - Iraq 2
PE - Perù 2
BG - Bulgaria 1
BS - Bahamas 1
CO - Colombia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
LB - Libano 1
NG - Nigeria 1
NI - Nicaragua 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.066
Città #
Dublin 247
Jacksonville 166
Hong Kong 112
Dearborn 94
Singapore 91
Wilmington 91
Chandler 84
Ashburn 75
Beijing 69
Los Angeles 38
Boardman 33
Piemonte 30
Lawrence 29
Princeton 29
San Mateo 27
Novara 26
Bremen 25
Moscow 23
Munich 21
Ann Arbor 20
New York 18
Andover 17
Seoul 17
Vercelli 14
Grafing 13
Montreal 13
Ho Chi Minh City 12
London 12
Milan 12
Turin 12
Buffalo 11
Brooklyn 10
Mexico City 10
Toronto 10
Dallas 9
Denver 9
Hefei 9
Helsinki 9
Boston 8
Cotonou 8
Frankfurt am Main 8
Poplar 8
Tokyo 8
Warsaw 8
Düsseldorf 7
Nanjing 7
Phoenix 7
Podenzano 7
Stockholm 7
Chennai 6
Ankara 5
Brussels 5
Hanoi 5
Mumbai 5
Orem 5
Roseto degli Abruzzi 5
Santa Clara 5
Seattle 5
São Paulo 5
Atlanta 4
Berlin 4
Florence 4
Guangzhou 4
Houston 4
Jinan 4
Kunming 4
Leawood 4
Norwalk 4
Redondo Beach 4
Roubaix 4
San Francisco 4
West Jordan 4
Augusta 3
City of London 3
Elk Grove Village 3
Falkenstein 3
Manchester 3
Nuremberg 3
Sacramento 3
San Jose 3
Tianjin 3
Trieste 3
Turku 3
Zanjan 3
Bangalore 2
Belo Horizonte 2
Brno 2
Bắc Ninh 2
Cagliari 2
Calgary 2
Casalecchio Di Reno 2
Castel Gandolfo 2
Castellazzo Bormida 2
Chicago 2
Cologno Monzese 2
Dhaka 2
Hackney 2
Johannesburg 2
Kemerovo 2
Lewisham 2
Totale 1.801
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 142
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 131
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 116
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 113
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 105
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 104
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 103
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 102
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 100
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 99
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 98
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 94
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 93
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 92
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 91
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 91
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 88
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 86
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 86
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 86
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 86
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 85
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 80
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 79
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 73
Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia 71
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 71
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 70
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 67
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 55
Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia 52
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 51
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 38
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 21
Totale 3.127
Categoria #
all - tutte 16.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 2 28 2 33 5 31 0
2021/2022257 1 2 24 33 25 1 29 3 20 20 46 53
2022/2023558 31 30 51 4 46 51 23 21 244 0 39 18
2023/2024258 21 17 15 5 35 6 38 12 0 5 23 81
2024/2025492 12 6 19 8 23 37 52 66 99 39 16 115
2025/2026741 100 74 85 227 214 41 0 0 0 0 0 0
Totale 3.127